Major Portfolio Expansion
Generate Investment Management Discloses New Stakes in Five Companies, Expanding Diverse Portfolio
Key Points
In Agnico Eagle Mines, Generate Investment Management Ltd disclosed a new 95,000-share position valued at about $19.283 million, representing roughly 0.9% of Generate's portfolio and ranking as the fund's 26th-largest holding.
The Agnico Eagle filing shows other major hedge funds expanding their positions in the stock in the prior quarter, including Capital World Investors (+572,473 shares to 21,338,277), Vanguard Group (+309,717 to 20,979,666), Van ECK Associates Corp (+3,062,705 to 17,225,477), TD Asset Management Inc (+165,263 to 9,665,456) and Mackenzie Financial Corp (+332,797 to 8,687,624), with institutional ownership around 68.34%.
Generate opened a new position in Repligen Corporation (RGEN) with 41,521 shares valued at about $4.892 million.
In Danaher Corporation (DHR), Generate acquired 69,057 shares valued at about $13.093 million; institutional ownership of DHR is about 79.05%, and Citi issued a Buy rating with a $230 price objective on the stock.
Generate bought 4,908 Regeneron Pharmaceuticals (REGN) shares for about $3.792 million. Separately, Director Arthur F. Ryan sold 100 REGN shares on May 1 at an average price of $705.24 (total $70,524), leaving him with 17,503 REGN shares; the sale was conducted under a pre-arranged 10b5-1 plan, and insiders own about 6.97% of REGN while institutional investors hold about 83.31%.
Generate Investment Management Ltd made five new equity purchases in the first quarter of 2026, with its biggest bet landing on gold miner Agnico Eagle Mines at roughly $19.3 million, according to MarketBeat. The fund also opened a $13.1 million stake in Danaher Corporation, cementing a broad push into healthcare and industrial stocks.
The five new positions — spanning mining, biotech, life sciences, semiconductors, and pharmaceuticals — total over $41 million in fresh capital. The moves were disclosed through standard SEC Form 13F filings, which require large institutional managers to report their holdings each quarter.
Danaher and Agnico Eagle Lead Generate's New Buys
Generate's largest single new position is 95,000 shares of Agnico Eagle Mines (AEM), valued at about $19.3 million, according to Fintel. That stake ranks as Generate's 26th-biggest holding and makes up roughly 0.9% of its estimated $1.8 billion portfolio. Generate is not alone — Capital World Investors added 572,473 shares and Vanguard added 309,717 shares in the same period, pushing total institutional ownership to about 68.34%.
The fund's second-largest new position is 69,057 shares of Danaher (DHR), worth about $13.1 million. Citi analysts back the stock with a Buy rating and a $230 price target, implying meaningful upside from Generate's Q1 entry point, according to MarketBeat. Institutional investors hold about 79.05% of Danaher's outstanding shares.
Biotech and Pharma Bets Round Out the Portfolio Shift
Generate also bought 41,521 shares of Repligen Corporation (RGEN) for about $4.9 million, according to Watchlist News. Repligen is a bioprocessing equipment maker, and the buy fits a broader institutional trend of targeting life sciences companies seen as stable, high-quality plays in 2026.
The fund added 4,908 shares of Regeneron Pharmaceuticals (REGN) for about $3.8 million. Regeneron posted Q1 2026 revenue of $3.61 billion, a 19% jump year-over-year, according to MarketBeat. Institutional investors own about 83.31% of REGN shares, reflecting strong large-fund confidence in the company's oncology pipeline.
Regeneron Director Sells 100 Shares Under Pre-Planned Trade
On May 1, Regeneron board member Arthur F. Ryan sold 100 REGN shares at an average price of $705.24 per share, netting $70,524. The sale was made under a Rule 10b5-1 plan — a legal arrangement where executives schedule trades in advance to avoid any appearance of insider trading, according to MarketBeat. Ryan still holds 17,503 REGN shares after the transaction.
The sale is a small move — just a 0.57% reduction in Ryan's total holdings. Insiders as a group still own about 6.97% of Regeneron. Analysts see the transaction as a routine liquidity event rather than a signal of weakening confidence in the company.
Small Texas Instruments Stake Signals Semiconductor Caution
Generate's smallest new position is just 1,981 shares of Texas Instruments (TXN), valued at about $385,000, according to Ticker Report. The modest size suggests a toe-in-the-water approach rather than a high-conviction bet. Analysts note that institutional interest in TXN reflects a broader search for stability in semiconductors after the supply chain disruptions of 2025.
Taken together, Generate's five new Q1 positions show a fund moving deliberately across sectors. The heaviest dollars went to gold mining and life sciences instrumentation. The lightest went to chips. The pattern suggests Generate is chasing quality and defensive growth as 2026 unfolds.
Sentiment
Mostly PositivePublishers
13
Articles
5
Reach
18
